Single blind, randomized study comparing clinical equivalence of TrusilkÃ?Â® (Healthium) and MersilkÃ?Â® (Johnson & Johnson) silk suture, for primary closure of mucosa in subjects undergoing planned surgical removal of mesioangular impacted mandibular third molar

Healthium Medtech PvtLtd formerly Sutures India Pvt Ltd0 个研究点目标入组 132 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Subjects having infected molar teeth or complicated impacted 3rd molar
•2. Pregnant or lactating women
•3. Subjects with history of allergy to silk or similar products
•4. Subjects on drugs like aspirin, blood thinners and anticoagulant therapy
•5. Subjects receiving any type of local and systemic drugs which can produce inflammation in gingival tissue
•6. Subjects with history of systemic diseases such as diabetes mellitus, tuberculosis, bleeding disorders, osteoporosis, unstable or life-threatening conditions, those undergoing radiation therapies.
•7. Subjects those who had the habit of drug abuse
•8. Subjects already participating in another trial
•9. Subjects who received an experimental drug or used an experimental medical device within 30 days prior to the planned start of procedure
•10. Subjects unlikely to comply with surgical procedure or complete the scheduled follow up visit, in the opinion of investigator
•11. Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center
•12. Other indication or the reason for exclusion, in the opinion of investigator

发起方

Healthium Medtech PvtLtd formerly Sutures India Pvt Ltd